Back to YC Companies
Sensible Biotechnologies
Summer 2021
Active
Unlocking the next generation of mRNA medicines
55 people View on YC
Sensible Biotechnologies at a glance
- Y Combinator batch
- Summer 2021
- Status
- Active
- Industry
- Healthcare
- Team size
- 55 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
Compare Sensible Biotechnologies with similar YC companies →
About Sensible Biotechnologies
The future of mRNA therapeutics is hampered by manufacturing challenges and unless solved, its exciting potential may never be realised. Sensible enables the next generation of mRNA medicines by turning living cells into factories producing abundant, highly stable and non-immunogenic mRNA in a scalable and cost-effective way.
Tags:
Synthetic Biology
Biotech
Manufacturing
Therapeutics
Biotechnology